Insulet (NASDAQ:PODD) Chief Operating Officer Eric Benjamin said the company remains focused on expanding adoption of automated insulin delivery, or AID, systems across large and underpenetrated diabetes markets, while addressing elevated early attrition among certain Type 2 diabetes customers.
Spe
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Those leading the charge have not only reali...
The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant ch...
As the Q2 earnings season wraps, let’s dig into this quarter’s best and worst performers in the patient monitoring industry, including Insulet (NASDAQ:PODD) ...
Large trillion-dollar companies are tightening their grip on the market, often by acquiring smaller rivals. This trend will likely pick up with new regulator...
Insulet’s second quarter was marked by strong revenue expansion but a sharp negative market reaction, as investors focused on emerging challenges in the comp...
Insulin delivery company Insulet Corporation (NASDAQ:PODD) reported Q2 CY2026 results topping the market’s revenue expectations, with sales up 23.5% year on ...
What Happened? Shares of insulin delivery company Insulet Corporation (NASDAQ:PODD) fell 20.5% in the afternoon session after the company reported strong sec...
Insulet (NASDAQ:PODD) reported second-quarter revenue growth of 23% on a constant-currency basis, supported by demand for its Omnipod insulin-delivery system in the U.S. and international markets, while raising its international outlook and reducing its U.S. and total-company revenue-growth expectat
Insulin delivery company Insulet Corporation (NASDAQ:PODD) announced better-than-expected revenue in Q2 CY2026, with sales up 23.5% year on year to $801.7 mi...
Insulin delivery company Insulet Corporation (NASDAQ:PODD) will be reporting earnings this Wednesday morning. Here’s what you need to know. Insulet beat anal...
